73. Keller C, Schmitz H, Theisen K and Zollner N. Regression of valvula? aortic stenosis due 
to homozygous familial hypercholesterolemia following plasmapheresis. Klin 
Wochenschr, Apr 1 1 986;64(7) :338-41 . 
74. Stein EA, Adolph R, Rice V, Glueck CJ and Spitz HB. Nonprogression of coronary artery 
atherosclerosis in homozygous familial hypercholesterolemia after 31 months of 
repetitive plasma exchange. Clin Cardiol, Mar 1986;9(3):1 15-9. 
75. Lupien PJ, Moorjani S, Gagne C, Brun LD, Lou M and Dagenais G. Long term treatment of 
two familial hypercholesterolemic heterozygote patients with batch affinity 
chromatography (BAC). Artery, 1 982;1 0(4) :286-300. 
76. Stoffel W and Demant T. Selective removal of apolipoprotein B-containing serum 
lipoproteins from blood plasma. Proc Natl Acad Sci USA, Jan 1981 ;78(1):61 1-5. 
77. Yodoyama S, Hayashi R, Satani M and Yamamoto A. Selective removal of low density 
lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis, 
Nov-Dec 1985;5(6):613-22. 
78. Gwynn JT. Probucol, high-density lipoprotein metabolism and reverse cholesterol 
transport. Am J Cardio, Jul 25 1988;62(3):48B-51B. 
79. Baker SG, Joffe Bi, Mendelsohn D and Seftel HC. Treatment of homozygous familial 
hypercholesterolemia with probucol. S Afr Med J, Jul 3 1982;62(1):7-11. 
80. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Oshima A, Yoshida H and Kawai C. Probucol 
prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic 
rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA, Aug 
1987;84(16):5928-31. 
81 . Leonard JV, Clarke M, McCartney FJ and Slack. Progression of atheroma in homozygous 
familial hypercholesterolemia during regular plasma exchange [letter]. Lancet, Oct 10 
1981 ;2(850):81 1 . 
82. Deckelbaum RJ, Lees RS, Small DM, Hedberg SE, Grundy SM. Failure of complete bile 
diversion and oral bile acid therapy in the treatment of homozygous familial 
hypercholesterolemia. N Engl J Med, Mar 3 1977;296(9):465-70. 
83. Schneider WJ, Brown MS, and Goldstein JL. Kinetic defects in the processing of the low 
density lipoprotein receptor in fibroblasts from WHHL rabbits and a family with 
familial hypercholesterolemia. Mol Biol Med, Oct 1983;1(3):353-67. 
84. Tanzawa K, Shimada Y, Kuroda M, Tsujita Y, Arai M, and Watanabe H. WHHL rabbit: a 
low density lipoprotein receptor-deficient animal model for familial 
hypercholesterolemia. FEBS, Aug 25 1 980;1 1 8(1 ):81 -4. 
85. Pittman RC, Carew TE, Attie AD, Witzman JL, Watanabe Y, and Steinberg D. Receptor- 
dependent and receptor-independent degradation of low density lipoprotein in normal 
rabbits and in receptor-deficient mutant rabbits. J Biol Chem, Jul 
1982;257(14):7994-8000. 
86. Kita T, Brown MS, Watanabe Y and Goldstein JL. Deficiency of low density lipoprotein 
receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial 
hypercholesterolemia. Proc Natl Acad Sci USA, Apr 1981 ;78(4):2268-72. 
87. Bilheimer DW, Watanabe Y and Kita T. Impaired receptor-mediated catabolism of low 
density lipoprotein in the WHHL rabbit, an animal model of familial 
hypercholesterolemia. Proc Natl Acad Sci USA, May 1982;79(10):3305-9. 
88. Kita T, Brown MS, Bilheimer DW and Goldstein JL. Delayed clearance of very low 
density and intermediate density lipoproteins with enhanced conversion to low density 
lipoproteins in WHHL rabbits. Proc Natl Acad USA, Sep 1979;79(18):5693-7. 
89. Wiederkehr JC, Kondos GT and Poliak R. Hepatocyte transplantation for the low-density 
lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation, 
Sep 1 990;50(3):466-71 . 
90. Danos 0 and Mulligan RC. Safe and efficient generation of recombinant retroviruses with 
amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA, Sep 
1 9 8 8 ; 8 5 ( 1 7) :6460-4. 
[ 200 ] 
Recombinant DNA Research, Volume 15 
